In future, it is likely that the clinical indications for GLP- 1RAs will expand, with pharmaceutical companies running various drug trials to substantiate a wider array of use cases, such as the reduction of cardiovascular risk and the treatment of chronic kidney disease
It should rise from baseline if the peptide is stimulating GH effectively
Side Effects & Safety Excellent safety profile in topical and subcutaneous use
Neuropharmacology 128:142151 Alvarez E, Martnez MD, Roncero I, Chowen JA, Garca-Cuartero B, Gispert JD, Sanz C, Vzquez P, Maldonado A, de Cceres J, Desco M, Pozo MA, Blzquez E (2005) The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem
A key feature of the program is the cost-sharing structure
Decisions made today across manufacturing and commercialisation will determine which companies are best positioned as these therapies move from promise to scale